Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacokinetic pilot study with imidazole 2-hydroxybenzoate using new analytical methods.

H P Kuemmerle, G Hitzenberger, G Nieder

    International Journal of Clinical Pharmacology, Therapy, and Toxicology
    |October 1, 1984
    PubMed
    Summary

    This pilot study evaluated new methods for quantifying imidazole, salicylic acid, and salicyluric acid in plasma and urine. The methods showed promise for pharmacokinetic analysis of imidazole 2-hydroxybenzoate.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    HIV and SARS-CoV-2 co-infection: cross-sectional findings from a German 'hotspot'.

    Infection·2021
    Same author

    Evaluation of pulsed electric fields technology for the improvement of subsequent carotenoid extraction from dried Rhodotorula glutinis yeast.

    Food chemistry·2020
    Same author

    Not all is perfect with Tenofovir alafenamide.

    HIV medicine·2019
    Same author

    Antiretroviral therapy options in people living with HIV at risk of or with osteoporosis : Comment on "Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis".

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2019
    Same author

    Safety analysis of German real-life cohort WIP shows rates of neuropsychiatric events leading to discontinuation of raltegravir therapy below 2.

    International journal of STD & AIDS·2019
    Same author

    Organochlorine and Organophosphorus Insecticides and Industrial Pollutants in the Milk Supplies of Ontario - 1983.

    Journal of food protection·2019

    Area of Science:

    • Pharmacology
    • Analytical Chemistry

    Background:

    • Imidazole 2-hydroxybenzoate is an antiphlogistic agent with analgesic and antipyretic properties.
    • Clinical investigations are ongoing for this novel compound.

    Purpose of the Study:

    • To assess novel quantification methods for imidazole, salicylic acid, and salicyluric acid in biological samples.
    • To evaluate the practicability of these methods for pharmacokinetic studies.
    • To analyze the pharmacokinetics of imidazole 2-hydroxybenzoate in healthy volunteers.

    Main Methods:

    • Development and application of new analytical techniques for metabolite detection.
    • Quantification of imidazole, salicylic acid, and salicyluric acid in plasma and urine.
    • Pharmacokinetic analysis following oral administration of imidazole 2-hydroxybenzoate in three healthy volunteers.

    Related Experiment Videos

    Main Results:

    • Imidazole metabolites were below detectable limits in plasma and urine.
    • Salicylic acid metabolites were also below the limit of detection (0.5 microgram/ml) in plasma.
    • Significant levels of salicyluric acid were detected in urine, while gentisinic acid was below detection limits.

    Conclusions:

    • The developed methods present challenges due to low metabolite concentrations, particularly for imidazole.
    • Salicyluric acid is a quantifiable metabolite in urine, aiding pharmacokinetic assessment.
    • Further research is recommended to refine analytical methods and fully elucidate the pharmacokinetics of imidazole 2-hydroxybenzoate.